Hakaim A G, Nalbandian M, Scott T
Department of Surgery, Boston Medical Center, Massachusetts 02118-2393, USA.
J Vasc Surg. 1998 Jan;27(1):154-7. doi: 10.1016/s0741-5214(98)70302-7.
Primary radiocephalic arteriovenous fistulas (RCAVFs) have classically been used for the initiation of dialysis. If a suitable forearm cephalic vein can be demonstrated, it is used to construct such a fistula. However, we have noted a tendency for RCAVF in patients with a history of diabetes mellitus (type I and type II) to remain patent but not mature to the point of cannulation. Therefore, the present study was undertaken.
Fifty-eight consecutive patients with diabetes who required initial access for hemodialysis at an urban medical center and tertiary Veterans Medical Center underwent creation of an RCAVF (n = 10), brachiocephalic arteriovenous fistula (BCAVF; n = 22), or transposed basilic vein arteriovenous fistula (TBAVF; n = 26). The vein used was determined by physical examination with tourniquet compression. If neither forearm or upper-arm cephalic veins were 2 mm in diameter, a TBAVF was created after venography. Patency was determined by Kaplan-Meier estimate; differences between groups were assessed by Fisher's exact test.
The 70% rate of nonmaturation of RCAVFs was significantly greater than the 27% rate for BCAVFs and 0% for TBAVFs (p < 0.05). The 33% cumulative primary patency rate at 18 months for RCAVFs was significantly less than 78% for BCAVFs and 79% for TBAVFs (p < 0.001). Within and between groups, there were no significant differences in age, gender, aspirin use, history of congestive heart failure, erythropoietin use, hematocrit level, history of peripheral vascular disease, or mortality rate.
In patients with renal failure and a history of diabetes, both primary BCAVFs and TBAVFs demonstrate significantly greater maturation and increased primary cumulative patency rates compared with RCAVFs; therefore, these autogenous conduits are considered to be optimal in this group of patients. Whether the discrepancy in lower-arm vein maturation is a result of a lack of compensatory increase in radial arterial flow or an intrinsic defect in the lower-arm cephalic vein is currently under investigation.
原发性桡动脉-头静脉动静脉内瘘(RCAVF)一直是启动透析的经典选择。如果能找到合适的前臂头静脉,就用它来构建这种内瘘。然而,我们注意到,有糖尿病病史(I型和II型)的患者中,RCAVF有保持通畅但未成熟到可穿刺的倾向。因此,开展了本研究。
在一家城市医疗中心和一家三级退伍军人医疗中心,58例需要初次建立血液透析通路的糖尿病患者接受了RCAVF(n = 10)、肱动脉-头静脉动静脉内瘘(BCAVF;n = 22)或转位贵要静脉动静脉内瘘(TBAVF;n = 26)的建立。使用的静脉通过扎止血带压迫的体格检查来确定。如果前臂或上臂头静脉直径均小于2 mm,则在静脉造影后建立TBAVF。通畅率通过Kaplan-Meier估计确定;组间差异通过Fisher精确检验评估。
RCAVF的未成熟率为70%,显著高于BCAVF的27%和TBAVF的0%(p < 0.05)。RCAVF在18个月时的33%的累积初级通畅率显著低于BCAVF的78%和TBAVF的79%(p < 0.001)。在组内和组间,年龄、性别、阿司匹林使用情况、充血性心力衰竭病史、促红细胞生成素使用情况、血细胞比容水平、外周血管疾病病史或死亡率均无显著差异。
在有肾衰竭和糖尿病病史的患者中,与RCAVF相比,原发性BCAVF和TBAVF均表现出显著更高的成熟度和更高的初级累积通畅率;因此,这些自体血管被认为是该组患者的最佳选择。目前正在研究前臂静脉成熟度差异是桡动脉血流缺乏代偿性增加的结果还是前臂头静脉固有缺陷的结果。